HC Wainwright & Co. Reiterates Buy on Prothena Corp, Maintains $90 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on Prothena Corp (NASDAQ:PRTA) and maintained a $90 price target.
July 18, 2023 | 10:15 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Prothena Corp's stock may see positive movement as HC Wainwright & Co. has reiterated a 'Buy' rating and maintained a $90 price target.
Analyst ratings and price targets can significantly influence investor sentiment and stock price. The reiteration of a 'Buy' rating and a high price target indicates strong confidence in the company's performance, which could lead to increased investor interest and a potential rise in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100